Open AccessReduced Toxicity, Myeloablative Conditioning Regimen with Busulfan, Fludarabine, Anti-Thymocyte Globulin and 400 Cgy TBI in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant for High-Risk Hematologic Malignancies
Author(s) -
Jenna Rossoff,
David A. Jacobsohn,
Soyang Kwon,
Morris Kletzel,
Reggie Duerst,
William T. Tse,
Jennifer Schneiderman,
Sonali Chaudhury
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.607
Subject(s) - medicine , busulfan , fludarabine , regimen , total body irradiation , hematopoietic stem cell transplantation , cumulative incidence , gastroenterology , surgery , toxicity , anti thymocyte globulin , transplantation , chemotherapy , cyclophosphamide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom